GLYCOCHOLIC ACID
General Information
| Mainterm | GLYCOCHOLIC ACID |
| Doc Type | NUL |
| CAS Reg.No.(or other ID) | 475-31-0 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 10140 |
| IUPAC Name | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid |
| InChI | InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1 |
| InChI Key | RFDAIACWWDREDC-FRVQLJSFSA-N |
| Canonical SMILES | CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C |
| Molecular Formula | C26H43NO6 |
| Wikipedia | glycocholate |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 465.631 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Complexity | 759.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B 6 O A A A A A A A A A A A A A A A A A A A A Y A A A A A w Y M A A A A A A A G D A A A A A H g A Q C A A A D x T h g A Y C C A L A A g A I A A G Q G A A A A A A A A A A A A I G I A A A C E B I A g C A E Q A A E F g C Q A A G Y 6 P S P g A A A A A A A A A D A A A Y A A D A A A Q A A C A A A A A = = |
| Topological Polar Surface Area | 127.0 |
| Monoisotopic Mass | 465.309 |
| Exact Mass | 465.309 |
| XLogP3 | None |
| XLogP3-AA | 2.9 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 33 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.8437 |
| Human Intestinal Absorption | HIA+ | 0.9543 |
| Caco-2 Permeability | Caco2- | 0.8855 |
| P-glycoprotein Substrate | Substrate | 0.7178 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7670 |
| Non-inhibitor | 0.5333 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8654 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.7881 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7788 |
| CYP450 2D6 Substrate | Non-substrate | 0.7730 |
| CYP450 3A4 Substrate | Substrate | 0.7391 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9382 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8426 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9826 |
| Non-inhibitor | 0.7952 | |
| AMES Toxicity | Non AMES toxic | 0.9154 |
| Carcinogens | Non-carcinogens | 0.9478 |
| Fish Toxicity | High FHMT | 0.9232 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9540 |
| Honey Bee Toxicity | Low HBT | 0.5835 |
| Biodegradation | Not ready biodegradable | 0.9798 |
| Acute Oral Toxicity | III | 0.6594 |
| Carcinogenicity (Three-class) | Non-required | 0.6707 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -5.0871 | LogS |
| Caco-2 Permeability | 0.1521 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.5186 | LD50, mol/kg |
| Fish Toxicity | 1.3474 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.2961 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Subclass | Bile acids, alcohols and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Glycinated bile acids and derivatives |
| Alternative Parents |
|
| Molecular Framework | Aliphatic homopolycyclic compounds |
| Substituents | Glycinated bile acid - Trihydroxy bile acid, alcohol, or derivatives - Hydroxy bile acid, alcohol, or derivatives - 3-hydroxysteroid - 12-hydroxysteroid - Hydroxysteroid - 3-alpha-hydroxysteroid - 7-hydroxysteroid - N-acyl-alpha-amino acid - N-acyl-alpha amino acid or derivatives - Alpha-amino acid or derivatives - Cyclic alcohol - Secondary alcohol - Polyol - Propargyl-type 1,3-dipolar organic compound - Organic 1,3-dipolar compound - Carboximidic acid - Monocarboxylic acid or derivatives - Carboximidic acid derivative - Carboxylic acid derivative - Carboxylic acid - Organooxygen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organic nitrogen compound - Carbonyl group - Alcohol - Organonitrogen compound - Aliphatic homopolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as glycinated bile acids and derivatives. These are compounds with a structure characterized by the presence of a glycine linked to a bile acid skeleton. |
From ClassyFire
Targets
- General Function:
- Transporter activity
- Specific Function:
- Ileal protein which stimulates gastric acid and pepsinogen secretion. Seems to be able to bind to bile salts and bilirubins. Isoform 2 is essential for the survival of colon cancer cells to bile acid-induced apoptosis.
- Gene Name:
- FABP6
- Uniprot ID:
- P51161
- Molecular Weight:
- 14371.245 Da
From T3DB